Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of proton pump inhibitor co-medication on mycophenolate mofetil absorption
NL-OMON59302Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mycophenolate mofetil, sponsored by Leiden University Medical Center. Primary endpoints: Maximum plasma concentration of mycophenolic acid and Area under the concentration-time curve of mycophenolic acid from 0 to 12 hours. Started Jul 2025; status: completed.
02
Drugs
mycophenolate mofetil
Beyond the preview
Go deeper on NL-OMON59302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59302.